Macroscopic Portal Vein Thrombosis in HCC Patients

被引:25
作者
Akkiz, Hikmet [1 ]
Carr, Brian I. [2 ]
Kuran, Sedef [1 ]
Karaogullarindan, Umit [1 ]
Uskudar, Oguz [1 ]
Tokmak, Salih [1 ]
Arslan, Burcu [1 ]
Doran, Figen [1 ]
Balli, Huseyin Tugsan [1 ]
Ulku, Abdulalh [1 ]
Akcam, Tolga Atilgan [1 ]
Bahceci, Halil Ibrahim [3 ]
Polat, Kamil Yalcin [4 ]
Ormeci, Necati [5 ]
Simsek, Halis [6 ]
Sonsuz, Abdullah [7 ]
Demir, Ali [8 ]
Altintas, Engin [9 ]
Demir, Mehmet [10 ]
Yalcin, Kendal [11 ]
Ekinci, Nazim [11 ]
Ozakyol, Aysegul Harmanci [12 ]
Yucesoy, Mehmet [13 ]
Uygun, Ahmet [14 ]
Guerra, Vito [15 ]
Delik, Anil [1 ]
Tokat, Yaman [16 ]
Yilmaz, Sezai [17 ]
Bektas, Ahmet [18 ]
Kilic, Murat [19 ]
机构
[1] Cukurova Univ, Gastroenterol Dept, Adana, Turkey
[2] Dokuz Eylul Univ, Izmir Biomed & Genome Inst, Izmir, Turkey
[3] Firat Univ, Elazig, Turkey
[4] Istanbul Mem Hosp, Istanbul, Turkey
[5] Ankara Univ, Ankara, Turkey
[6] Hacettepe Univ, Ankara, Turkey
[7] Istanbul Cerrahpasa Univ, Istanbul, Turkey
[8] Konya Necmettin Erbakan Univ, Konya, Turkey
[9] Mersin Univ, Mersin, Turkey
[10] Hatay Mustafa Kemal Univ, Antakya, Turkey
[11] Dicle Univ, Diyarbakir, Turkey
[12] Eskisehir Osmangazi Univ, Eskisehir, Turkey
[13] Erciyes Univ, Kayseri, Turkey
[14] Haydarpasa Sultan Abdulhamid Egitim Arastirma Hos, Istanbul, Turkey
[15] IRCCS Saverio de Bellis, Natl Inst Digest Dis, Trials Ctr, Bari, Italy
[16] Florence Nightingale Hosp, Istanbul, Turkey
[17] Inonu Univ, Malatya, Turkey
[18] Ondokuz Mayis Univ, Kurupelit, Turkey
[19] Izmir Kent Hosp, Izmir, Turkey
关键词
GAMMA-CARBOXY PROTHROMBIN; UNRESECTABLE HEPATOCELLULAR-CARCINOMA; AUTOLOGOUS GROWTH-FACTOR; COMPUTED-TOMOGRAPHY; PROGNOSTIC-FACTORS; ALPHA-FETOPROTEIN; VENOUS INVASION; TUMOR; SURVIVAL; ULTRASOUND;
D O I
10.1155/2018/3120185
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Macroscopic portal vein invasion (PVT) by hepatocellular carcinoma (HCC) in the liver is one of the most important negative prognostic factors for HCC patients. The characteristics of a large cohort of such patients were examined. We found that the percent of patients with PVT significantly increased with increasing maximum tumor diameter (MTD), from 13.7% with tumors of MTD <5cm to 56.4% with tumors of MTD >10cm. There were similar numbers of HCC patients with very large tumors with and without PVT. Thus, MTD alone was insufficient to explain the presence of PVT, as were high AFP levels, since less than 50% of high AFP patients had PVT. However, the percent of patients with PVT was also found to significantly increase with increasing blood alpha-fetoprotein (AFP) levels and tumormultifocality. A logistic regressionmodel that included these 3 factors together showed an odds ratio of 17.9 for the combination of MTD >5.0cm plus tumor multifocality plus elevated AFP, compared to low levels of these 3 parameters. The presence or absence of macroscopic PVT may therefore represent different HCC aggressiveness phenotypes, as judged by a significant increase in tumor multifocality and AFP levels in the PVT positive patients. Factors in addition to MTD and AFP must also contribute to PVT development.
引用
收藏
页数:8
相关论文
共 42 条
[31]   Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma [J].
Rossi, Sandro ;
Ghittoni, Giorgia ;
Ravetta, Valentina ;
Viera, Francesca Torello ;
Rosa, Laura ;
Serassi, Martina ;
Scabini, Mara ;
Vercelli, Alessandro ;
Tinelli, Carmine ;
Dal Bello, Barbara ;
Burns, Peter N. ;
Calliada, Fabrizio .
EUROPEAN RADIOLOGY, 2008, 18 (08) :1749-1756
[32]   Hepatocellular carcinoma in Central Europe:: prognostic features and survival [J].
Schöniger-Hekele, M ;
Müller, C ;
Kutilek, M ;
Oesterreicher, C ;
Ferenci, P ;
Gangl, A .
GUT, 2001, 48 (01) :103-109
[33]   DES-GAMMA-CARBOXY PROTHROMBIN AND PROLIFERATIVE ACTIVITY OF HEPATOCELLULAR-CARCINOMA [J].
SUEHIRO, T ;
MATSUMATA, T ;
ITASAKA, H ;
TAKETOMI, A ;
YAMAMOTO, K ;
SUGIMACHI, K .
SURGERY, 1995, 117 (06) :682-691
[34]   Des-γ-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma [J].
Suzuki, M ;
Shiraha, H ;
Fujikawa, T ;
Takaoka, N ;
Ueda, N ;
Nakanishi, Y ;
Koike, K ;
Takaki, A ;
Shiratori, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (08) :6409-6415
[35]   Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma [J].
Tarantino, Luciano ;
Ambrosino, Pasquale ;
Di Minno, Matteo Nicola Dario .
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (32) :9457-9460
[36]   COMPUTED-TOMOGRAPHY IN THE EVALUATION OF THE PORTAL VENOUS SYSTEM [J].
TAYLOR, CR .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1992, 14 (02) :167-172
[37]   Benign and malignant portal vein thrombosis: Differentiation by CT characteristics [J].
Tublin, ME ;
Dodd, GD ;
Baron, RL .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1997, 168 (03) :719-723
[38]  
WANG ZQ, 1995, HEPATOLOGY, V22, P876, DOI 10.1016/0270-9139(95)90310-0
[39]   Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis [J].
Yamamoto, Yusuke ;
Ikoma, Hisashi ;
Morimura, Ryo ;
Shoda, Katsutoshi ;
Konishi, Hirotaka ;
Murayama, Yasutoshi ;
Komatsu, Shuhei ;
Shiozaki, Atsushi ;
Kuriu, Yoshiaki ;
Kubota, Takeshi ;
Nakanishi, Masayoshi ;
Ichikawa, Daisuke ;
Fujiwara, Hitoshi ;
Okamoto, Kazuma ;
Sakakura, Chouhei ;
Ochiai, Toshiya ;
Otsuji, Eigo .
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (01) :246-253
[40]   Des-γ-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathway [J].
Yue, Pan ;
Gao, Zu-Hua ;
Xue, Xia ;
Cui, Shu-Xiang ;
Zhao, Cui-Rong ;
Yuan, Yi ;
Yin, Zhe ;
Inagaki, Yoshinori ;
Kokudo, Norihiro ;
Tang, Wei ;
Qu, Xian-Jun .
EUROPEAN JOURNAL OF CANCER, 2011, 47 (07) :1115-1124